Publication

HIRERIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against HireRight Holdings Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024

Investors have until June 3, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 3, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, HireRight’s stock price fell $0.88 per share, or 7.5%, to close at $10.75 per share on January 19, 2023.
  • At the time of the Complaint's filing, HireRight’s common stock continue to trade below the $19.00 per share IPO price.

BrightSpring Health Services Applauds Hundreds of Award-Winning Employees for their Recognition of Outstanding Service and Care

Retrieved on: 
Thursday, April 4, 2024

LOUISVILLE, Ky., April 04, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG) applauds its most recent employees and programs for their dedicated service, care, and innovation, which has resulted in ongoing and additional national recognition by industry publications and trade associations.

Key Points: 
  • LOUISVILLE, Ky., April 04, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG) applauds its most recent employees and programs for their dedicated service, care, and innovation, which has resulted in ongoing and additional national recognition by industry publications and trade associations.
  • “At BrightSpring, we’re committed to fostering a workplace and culture that provide employees with the tools and opportunities to be successful in working with our customers and partners and providing care for complex patient populations,” said BrightSpring President and CEO, Jon Rousseau.
  • “So many of our employees go above and beyond, with a commitment to people, quality, and outcomes.
  • To view a full list of BrightSpring external award winners and learn more about the Company’s national recognitions, visit https://www.brightspringhealth.com/ .

Urology Care Foundation Announces 2024 Research Awards of Distinction

Retrieved on: 
Thursday, April 4, 2024

BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.

Key Points: 
  • BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.
  • "We are optimistic about the future of urologic research with the selection of the recipients of this year’s Urology Care Foundation Research Awards,” said Harris M. Nagler, MD, Urology Care Foundation President.
  • “We are thrilled with the Urology Care Foundation Research Awards of Distinction awardees this year,” said Steven Kaplan, MD, Chair of the AUA’s Research Council.
  • The awardees will be celebrated at the Urology Care Foundation Research Honors Program held at the AUA Annual Meeting in May 2024.

HireRight Holdings Corp. News: Robbins LLP Informs Investors of Class Action Filed Against HRT

Retrieved on: 
Wednesday, April 3, 2024

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all stockholders who purchased or otherwise acquired HireRight Holdings Corp. (NYSE: HRT) securities pursuant to or traceable to the Offering Documents issued in connection with the Company’s October 2021 initial public offering ("IPO").

Key Points: 
  • SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all stockholders who purchased or otherwise acquired HireRight Holdings Corp. (NYSE: HRT) securities pursuant to or traceable to the Offering Documents issued in connection with the Company’s October 2021 initial public offering ("IPO").
  • The Allegations: Robbins LLP is Investigating the Allegations that HireRight Holdings Corp. (HRT) Filed Misleading Documents in Connection with its IPO
    On November 1, 2021, HireRight began publicly trading on the NYSE under the ticker symbol HRT.
  • What Now: You may be eligible to participate in the class action against HireRight Holdings Corp. Shareholders who want to serve as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Creative Health Care Management Donna Wright Awarded the 2024 Marlene Kramer Lifetime Achievement Award

Retrieved on: 
Wednesday, April 3, 2024

This prestigious honor, the pinnacle of recognition within the Association for Nursing Professional Development (ANPD), is awarded to individuals who have profoundly influenced the nursing profession and the organization itself.

Key Points: 
  • This prestigious honor, the pinnacle of recognition within the Association for Nursing Professional Development (ANPD), is awarded to individuals who have profoundly influenced the nursing profession and the organization itself.
  • Established by the ANPD Board of Directors in 2016 and first awarded to Dr. Marlene Kramer in 2017, the award is a testament to enduring impact and dedication within nursing research and the nursing community.
  • “Creative Health Care Management (CHCM) proudly announces that our very own Donna Wright has been honored with the 2024 Marlene Kramer Lifetime Achievement Award by the Association for Nursing Professional Development (ANPD).
  • This prestigious award, to be presented at the ANPD Aspire Convention, acknowledges Wright’s significant contributions to nursing professional development.

Remembering the Legacy of Gleda M. Estes: A Pioneer in Model Rocketry and its Educational Opportunities

Retrieved on: 
Wednesday, April 3, 2024

Gleda passed away peacefully on March 30, 2024 at the age of 92, leaving behind a legacy that will continue to inspire generations to come.

Key Points: 
  • Gleda passed away peacefully on March 30, 2024 at the age of 92, leaving behind a legacy that will continue to inspire generations to come.
  • Gleda Kane was born on March 4, 1932 to Lester and Anna Belle Kane in a farming community near Clarinda, Iowa.
  • It was in chemistry class at Central that Gleda met her husband, Vernon Estes.
  • As a co-founder of Estes Industries, Gleda was Vern’s primary support and partner in their new business venture into the space-age hobby of model rocketry.

Unveiling the Future: Voting Open for Global Blockchain Awards Recognizing Web3 Excellence!

Retrieved on: 
Wednesday, April 3, 2024

Dubai, April 03, 2024 (GLOBE NEWSWIRE) --  VAP Group is proud to announce the launch of the Global Blockchain Awards, honoring the brightest minds and boldest innovators in the Web3 space. Set against the backdrop of the esteemed Global Blockchain Show, this exclusive awards ceremony will take place on April 15, 2024, at the Grand Hyatt Dubai, preceding the main event scheduled for April 16th and 17th.

Key Points: 
  • As a highlight of Dubai's bustling blockchain scene, the Global Blockchain Awards promise to be an unforgettable night celebrating the outstanding contributions of global Web3 leaders.
  • Parmar remarks, "Honoring the Web3 changemakers not only recognizes their achievements but also fosters global dissemination of ideas and innovations through the Global Blockchain Awards ceremony."
  • We are proud to announce that the Global Blockchain Awards are sponsored by VAP Group, a leading consulting firm in the blockchain ecosystem.
  • Don't miss your chance to be part of this historic event at the Global Blockchain Show 2024, our inaugural blockchain event.

RAPID + TCT 2024: North America’s Largest Additive Manufacturing Event Returns to the West Coast With New Features and Experiences

Retrieved on: 
Tuesday, April 2, 2024

LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- RAPID + TCT 2024, the largest, most influential additive manufacturing (AM) event in North America, is returning to the West Coast for the first time in nine years.

Key Points: 
  • LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- RAPID + TCT 2024, the largest, most influential additive manufacturing (AM) event in North America, is returning to the West Coast for the first time in nine years.
  • The two industry leaders in 3D-technology events, SME and Rapid News Publications, team up to produce the annual RAPID + TCT event, each year better than the previous.
  • “Known worldwide as North America’s largest additive manufacturing and industrial 3D printing event, RAPID + TCT provides everything you need to know about the latest 3D-technologies, all under one roof,” said Robert “Bob” Willig, executive director and CEO of SME.
  • Winners will receive main stage recognition, a fully equipped booth guaranteed at RAPID + TCT 2025 and media visibility.

Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors

Retrieved on: 
Tuesday, April 2, 2024

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors.

Key Points: 
  • VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors.
  • Dr. Olla is an expert in breath technologies, breathomics, healthcare innovation, artificial and medical informatics.
  • Dr. Olla is one of only a handful of scientists globally who has ever conducted delta-9 THC analysis in blood and breath.
  • Dr. Olla is an associate professor at University of Detroit Mercy in Michigan and is the Vice Chair of the MedHealth Consortium.

Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee

Retrieved on: 
Tuesday, April 2, 2024

DIEPPE, New Brunswick, April 02, 2024 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a medical device firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that Dr. Paul Harasymowycz, renowned ophthalmologist and recognized innovator in MIGS techniques, has joined Hexiris’s Scientific Committee.

Key Points: 
  • DIEPPE, New Brunswick, April 02, 2024 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a medical device firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that Dr. Paul Harasymowycz, renowned ophthalmologist and recognized innovator in MIGS techniques, has joined Hexiris’s Scientific Committee.
  • “We are proud that Dr. Harasymowycz has agreed to join our scientific committee,” said Dr. Nir Shoham-Hazon, Co-Founder and Co-CEO of Hexiris.
  • Over the past 20 years, Dr. Harasymowycz has distinguished himself through his extensive research and more than 90 publications in national and international scientific journals, and book chapters on glaucoma.
  • As a result, the Hexiris MIGS Solution is expected to generate considerable cost benefits for the health system.